Table 4.
Frequencies and Percentages of Any Adverse Event Reported after Yttrium-90 Radioembolization at 3 and 6 Months
| Toxicity | Frequency of any CTCAE |
|||
|---|---|---|---|---|
| 3 mo | % | 6 mo | % | |
| Clinical toxicities | ||||
| Fatigue | 2 | 7 | 1 | 3 |
| Abdominal pain | 2 | 7 | 4 | 13 |
| Ascites | 1 | 3 | 2 | 7 |
| Encephalopathy | 1 | 3 | 1 | 3 |
| Anorexia | 0 | 0 | 0 | 0 |
| Fever | 0 | 0 | 0 | 0 |
| Nausea | 3 | 10 | 0 | 0 |
| Vomiting | 0 | 0 | 1 | 3 |
| Death | 1 | 3 | 1 | 3 |
| Any CTCAE | 6 | 20 | 4 | 13 |
| Severe >3 CTCAE | 0 | 0 | 1 | 3 |
| Laboratory toxicities | ||||
| Total bilirubin | 5 | 17 | 3 | 10 |
| ALT | 1 | 3 | 2 | 7 |
| AST | 4 | 13 | 2 | 7 |
| Alkaline phosphatase | 5 | 17 | 1 | 3 |
| Albumin | 4 | 13 | 3 | 10 |
| Creatinine | 3 | 10 | 2 | 7 |
| Hyponatremia | 7 | 23 | 2 | 7 |
| WBC | 3 | 10 | 1 | 3 |
| Anemia | 3 | 10 | 2 | 7 |
| Platelets | 7 | 23 | 5 | 17 |
| Any CTCAE | 26 | 87 | 18 | 60 |
| Severe >3 CTCAE | 6 | 20 | 4 | 13 |
Note–The one patient death over the study period was secondary to transplantation complications.
ALT = alanine transaminase; AST = aspartate aminotransferase; CTCAE = Common Terminology for Clinical Adverse Events; WBC = white blood cell.